Study details
Enrolling now
Pharmacological Modulation of Brain Oscillations in Memory Processing
University of Texas Southwestern Medical Center
NCT IDNCT05594017ClinicalTrials.gov data as of Apr 2026
Phase
EARLY_PHASE1
Target enrollment
60
Study length
about 7.8 years
Ages
18–55
Locations
1 site in TX
What this study is about
Researchers are testing whether scopolamine affects brain activity related to memory. The trial will measure brain activity in epileptic patients undergoing intracranial surgery, comparing the effects of scopolamine and a placebo on memory encoding and retrieval.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Placebo
- 2.Take Scopolamine (0.4mg)
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Oral
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
scopolamine
Drug routes
oral (Oral Tablet)
Body systems
Neurology